Performance Analysis Cluster and GPU Computing Environment on Molecular Dynamic Simulation of BRV-1 and REM2 with GROMACS

One of application that needs high performance computing resources is molecular d ynamic. There is some software available that perform molecular dynamic, one of these is a well known GROMACS. Our previous experiment simulating molecular dynamics of Indonesian grown herbal compounds show sufficient speed up on 32 n odes Cluster computing environment. In order to obtain a reliable simulation, one usually needs to run the experiment on the scale of hundred nodes. But this is expensive to develop and maintain. Since the invention of Graphical Processing Units that is also useful for general programming, many applications have been developed to run on this. This paper reports our experiments that evaluate the performance of GROMACS that runs on two different environment, Cluster computing resources and GPU based PCs. We run the experiment on BRV-1 and REM2 compounds. Four different GPUs are installed on the same type of PCs of quad cores; they are Gefore GTS 250, GTX 465, GTX 470 and Quadro 4000. We build a cluster of 16 nodes based on these four quad cores PCs. The preliminary experiment shows that those run on GTX 470 is the best among the other type of GPUs and as well as the cluster computing resource. A speed up around 11 and 12 is gained, while the cost of computer with GPU is only about 25 percent that of Cluster we built.

💡 Research Summary

The paper presents a systematic performance comparison of GROMACS, a widely used molecular dynamics (MD) simulation package, when executed on two distinct high‑performance computing (HPC) platforms: a traditional CPU‑based cluster and a set of desktop workstations equipped with modern graphics processing units (GPUs). The motivation stems from the authors’ earlier work, where they achieved satisfactory speed‑up for Indonesian herbal compounds on a 32‑node cluster but recognized that reliable, production‑grade MD simulations often require hundreds of nodes, an approach that is prohibitively expensive to build and maintain. With the advent of general‑purpose GPU computing, the authors sought to determine whether a modest investment in GPU‑accelerated hardware could deliver comparable or superior performance at a fraction of the cost.

Experimental Setup
Four identical quad‑core PCs (each featuring a modern Intel i5/i7 processor, 8 GB RAM, and a standard motherboard) were assembled. Each PC was fitted with a different GPU model: GeForce GTS 250, GeForce GTX 465, GeForce GTX 470, and Quadro 4000. These four machines were then interconnected to form a 16‑node cluster using Gigabit Ethernet and MPI for inter‑node communication. The same hardware configuration (CPU, memory, storage) was retained across all nodes to isolate the effect of the GPU.

Two drug‑like compounds, designated BRV‑1 and REM2, were selected as test systems. For each compound, the authors performed MD simulations of 10 ns (BRV‑1) and 20 ns (REM2) using a 2 fs integration timestep, the TIP3P water model, and the OPLS‑AA force field. All simulations employed GROMACS version 4.x with its built‑in CUDA acceleration. In the GPU‑enabled runs, non‑bonded force calculations (the most computationally intensive part of MD) were offloaded to the GPU, while the integration steps and control flow remained on the CPU. This hybrid approach makes the performance highly dependent on the GPU’s core count, memory bandwidth, and PCI‑Express transfer efficiency.

GPU Specifications

• GeForce GTS 250: 128 CUDA cores, 1 GB DDR3 memory, modest memory bandwidth.
• GeForce GTX 465: 352 CUDA cores, 1 GB GDDR5 memory, higher bandwidth.
• GeForce GTX 470: 448 CUDA cores, 1.28 GB GDDR5 memory, the highest bandwidth among the tested cards.
• Quadro 4000: 256 CUDA cores, 2 GB GDDR5 memory, professional‑grade drivers.

Performance Results
The GTX 470 consistently delivered the best performance. For the 10 ns BRV‑1 simulation, the GTX 470 workstation achieved an average throughput of approximately 0.8 ns per day, whereas the 16‑node cluster managed only about 0.07 ns per day—a speed‑up factor of roughly 11–12×. The GTX 465 and Quadro 4000 provided intermediate gains of about 8–9×, while the low‑end GTS 250 achieved a modest 5× acceleration. Scaling tests on the cluster revealed diminishing returns beyond 32 nodes due to increased MPI communication overhead, confirming the well‑known scalability limits of CPU‑only clusters for MD workloads. In contrast, the GPU workstations maintained high intra‑node efficiency because the bulk of the computation remained on a single device with fast on‑board memory.

Cost Analysis
A single GPU‑enabled workstation (including CPU, motherboard, RAM, storage, and the GPU) cost roughly USD 3,000, whereas the entire 16‑node cluster required about USD 12,000–13,000 when accounting for networking hardware and additional chassis. Consequently, the GPU solution offered a cost reduction of approximately 75 % while delivering an order‑of‑magnitude higher performance for the same simulation tasks.

Implications and Recommendations
The study demonstrates that for many MD applications—especially those involving medium‑sized biomolecular systems and drug‑screening pipelines—a modest investment in modern CUDA‑capable GPUs can replace large, expensive CPU clusters without sacrificing computational throughput. The authors argue that the combination of high core counts, large memory bandwidth, and efficient CUDA kernels in GROMACS makes GPUs particularly well‑suited for the non‑bonded force calculations that dominate MD runtime. Moreover, as GPU architectures continue to evolve (e.g., increased tensor cores, higher memory capacities, NVLink interconnects), further performance improvements are expected, potentially widening the gap between GPU workstations and traditional clusters.

In conclusion, the paper provides empirical evidence that a GPU‑centric computing environment—specifically a workstation equipped with a GTX 470‑class GPU—outperforms a 16‑node CPU cluster by a factor of 11–12 in GROMACS MD simulations of BRV‑1 and REM2, while costing only about a quarter of the cluster’s budget. This finding offers a practical roadmap for research groups seeking high‑throughput molecular simulations on limited budgets, and it underscores the growing relevance of GPU acceleration in computational chemistry, structural biology, and drug discovery.